Skip to content
Legislation to modernize the clinical drug development paradigm should be patient-centric, effective and inclusive, Biotechnology Innovation Organization (BIO) Chief Scientific Officer Dr. Cartier Esham […]
BIO’s CSO testifies at congressional hearing on PDUFA riders Read More »
The United States, European Union, India, and South Africa “reached a consensus on key elements of a long-sought intellectual property waiver for COVID-19 vaccines,”
Agreement reported on waiver of COVID vaccine IP protections Read More »
Bacterial and fungal infections that follow on the back of SARS-CoV-2 coronavirus have forced doctors to increase the use of antibiotics and antifungal medications,
Squash Superbugs Day of Action to address medical and market challenges of AMR Read More »
Brain health appears to have an equity problem. According to a recent report by Biogen, “Neurological conditions such as stroke, Alzheimer’s disease and Parkinson’s
Brain Awareness Week: COVID-19, brain health, and inequity Read More »
Russia’s decision to wage war on Ukraine brought home in very dramatic terms the urgency of weaning ourselves from fossil fuels, and creating more
War brings home urgency of alternative fuels, food stability Read More »
The U.S. Food and Drug Administration (FDA) on Friday announced its first “low-risk determination” for a gene-edited food animal. The FDA made the decision
FDA greenlights marketing gene-edited cattle for food Read More »
California Gov. Gavin Newsom last month signed a bill aimed at restoring two crucial tax benefits for biotech companies. Reinstated after policy efforts from
California reinstates tax incentives to support biotech companies Read More »
